Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Shorts -- Ignore unavailable to you. Want to Upgrade?

To: poodle who wrote (52)	1/29/1998 11:03:00 PM
From: Fernando Saldanha	Read Replies (1) \| Respond to of 61

poodle, I have been reading about telomerase and what it can do for a while, and only recently I heard about GERN. The problem with shorting this stock is that the potential of this stuff is so great. Consider the two possible outcomes of research on telomerase: a cure for cancer and reversal of human aging. Even if very limited success is met with in any one of these two areas the stock would soar. Please do not misunderstand. I am not long this stock. But the only way I would take the short side is with puts. Best regards.